{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:38:04Z","timestamp":1777628284646,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003512","name":"State Administration of Foreign Experts Affairs","doi-asserted-by":"publisher","award":["111-2-07"],"award-info":[{"award-number":["111-2-07"]}],"id":[{"id":"10.13039\/501100003512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872850"],"award-info":[{"award-number":["81872850"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673435"],"award-info":[{"award-number":["81673435"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012172","name":"Double First Class University Plan","doi-asserted-by":"publisher","award":["CPU2018GF08"],"award-info":[{"award-number":["CPU2018GF08"]}],"id":[{"id":"10.13039\/501100012172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011360","name":"State Key Laboratory of Natural Medicines","doi-asserted-by":"publisher","award":["SKLNMZZCX201822"],"award-info":[{"award-number":["SKLNMZZCX201822"]}],"id":[{"id":"10.13039\/501100011360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2019ZX09201001"],"award-info":[{"award-number":["2019ZX09201001"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013279","name":"National Key New Drug Creation and Manufacturing Program, Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.neuropharm.2020.108335","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T11:56:38Z","timestamp":1600862198000},"page":"108335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Potential therapeutic role of fibroblast growth factor 21 in neurodegeneration: Evidence for ameliorating parkinsonism via silent information regulator 2 homolog 1 and implication for gene therapy"],"prefix":"10.1016","volume":"181","author":[{"given":"Yingjie","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guixia","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangdong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108335_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuroscience.2015.05.023","article-title":"Glucagon-like peptide-1 regulates mitochondrial biogenesis and tau phosphorylation against advanced glycation end product-induced neuronal insult: studies in vivo and in vitro","volume":"300","author":"An","year":"2015","journal-title":"Neuroscience"},{"issue":"10103","key":"10.1016\/j.neuropharm.2020.108335_bib2","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0140-6736(17)31585-4","article-title":"Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Athauda","year":"2017","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.neuropharm.2020.108335_bib3","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nm.3249","article-title":"FGF21 regulates metabolism and circadian behavior by acting on the nervous system","volume":"19","author":"Bookout","year":"2013","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108335_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"28","key":"10.1016\/j.neuropharm.2020.108335_bib5","doi-asserted-by":"crossref","first-page":"12553","DOI":"10.1073\/pnas.1006962107","article-title":"Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway","volume":"107","author":"Chau","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.neuropharm.2020.108335_bib6","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s11357-011-9303-8","article-title":"Amelioration of neurodegeneration changes in cellular and rat models of diabetes-related Alzheimer's disease by extendin-4","volume":"34","author":"Chen","year":"2012","journal-title":"Age"},{"key":"10.1016\/j.neuropharm.2020.108335_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuroscience.2013.10.038","article-title":"Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation","volume":"256","author":"Chen","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108335_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101133","article-title":"Fibroblast growth factor 21 ameliorates neurodegeneration in rat and cellular models of Alzheimer's disease","volume":"22","author":"Chen","year":"2019","journal-title":"Redox biol"},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108335_bib9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.bbadis.2018.11.012","article-title":"Evidence of metabolic memory-induced neurodegeneration and the therapeutic effects of glucagon-like peptide-1 receptor agonists via Forkhead box class O","volume":"1865","author":"Chen","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"9","key":"10.1016\/j.neuropharm.2020.108335_bib10","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1111\/jcmm.15190","article-title":"Fibroblast growth factor 21 alleviates acute pancreatitis via activation of the Sirt1-autophagy signalling pathway","volume":"24","author":"Chen","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"8","key":"10.1016\/j.neuropharm.2020.108335_bib11","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2020.108335_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.nbd.2014.04.012","article-title":"Neuroprotective effects of leptin in the context of obesity and metabolic disorders","volume":"72","author":"Davis","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.neuropharm.2020.108335_bib13","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Aging and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.neuropharm.2020.108335_bib14","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/me.2010-0142","article-title":"Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse","volume":"24","author":"Fon Tacer","year":"2010","journal-title":"Mol. Endocrinol."},{"issue":"10","key":"10.1016\/j.neuropharm.2020.108335_bib15","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/mnfr.201600111","article-title":"Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of \u03b1-synuclein via SIRT1-deacetylated LC3","volume":"60","author":"Guo","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108335_bib16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.neuron.2014.01.028","article-title":"SIRT1 in neurodevelopment and brain senescence","volume":"81","author":"Herskovits","year":"2014","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.neuropharm.2020.108335_bib17","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.peptides.2007.10.007","article-title":"The fasting polypeptide FGF21 can enter brain from blood","volume":"28","author":"Hsuchou","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2020.108335_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1101\/sqb.2000.65.297","article-title":"Sir2: an NAD-dependent histone deacetylase that connects chromatin silencing, metabolism, and aging","volume":"65","author":"Imai","year":"2000","journal-title":"Cold Spring Harbor Symp. Quant. Biol."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108335_bib19","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s11064-016-2110-y","article-title":"Sirtuins and their roles in brain aging and neurodegenerative disorders","volume":"42","author":"J\u0119\u015bko","year":"2017","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108335_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nm.2558","article-title":"Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets","volume":"18","author":"Jiang","year":"2011","journal-title":"Nat. Med."},{"issue":"19","key":"10.1016\/j.neuropharm.2020.108335_bib21","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1101\/gad.13.19.2570","article-title":"The SIR2\/3\/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms","volume":"13","author":"Kaeberlein","year":"1999","journal-title":"Genes Dev."},{"issue":"5","key":"10.1016\/j.neuropharm.2020.108335_bib22","first-page":"634","article-title":"Sirtuins, cell senescence, and vascular aging","volume":"32","author":"Kida","year":"2016","journal-title":"Can. J. Cardiol."},{"issue":"4","key":"10.1016\/j.neuropharm.2020.108335_bib23","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1073\/pnas.0806720106","article-title":"GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism","volume":"106","author":"Li","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108335_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2193-1801-3-2","article-title":"Fibroblast growth factor-21 enhances mitochondrial functions and increases the activity of PGC-1\u03b1 in human dopaminergic neurons via Sirtuin-1","volume":"3","author":"M\u00e4kel\u00e4","year":"2014","journal-title":"SpringerPlus"},{"key":"10.1016\/j.neuropharm.2020.108335_bib25","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.neuropharm.2015.11.020","article-title":"Peroxisome proliferator-activated receptor-\u03b3 (PPAR\u03b3) agonist is neuroprotective and stimulates PGC-1\u03b1 expression and CREB phosphorylation in human dopaminergic neurons","volume":"102","author":"M\u00e4kel\u00e4","year":"2016","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.neuropharm.2020.108335_bib26","doi-asserted-by":"crossref","first-page":"e823","DOI":"10.1212\/WNL.0000000000006955","article-title":"Type 2 diabetes mellitus, brain atrophy, and cognitive decline","volume":"92","author":"Moran","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2020.108335_bib27","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00018-011-0850-z","article-title":"Transgenic expression and activation of PGC-1\u03b1 protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease","volume":"69","author":"Mud\u00f2","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"issue":"Pt 5","key":"10.1016\/j.neuropharm.2020.108335_bib28","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1042\/BST0331033","article-title":"Insulin and cholesterol pathways in neuronal function, memory and neurodegeneration","volume":"33","author":"Nelson","year":"2005","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108335_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-4781(00)00067-1","article-title":"Identification of a novel FGF, FGF-21, preferentially expressed in the liver","volume":"1492","author":"Nishimura","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"s2","key":"10.1016\/j.neuropharm.2020.108335_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JAD-2011-102070","article-title":"Leptin induces proliferation of neuronal progenitors and neuroprotection in a mouse model of Alzheimer's disease","volume":"24","author":"Perez-Gonzalez","year":"2011","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.neuropharm.2020.108335_bib31","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00109-004-0552-1","article-title":"Neurodegenerative disorders associated with diabetes mellitus","volume":"82","author":"Ristow","year":"2004","journal-title":"J. Mol. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108335_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11011-015-9789-3","article-title":"Potential roles of fibroblast growth factor 21 in the brain","volume":"31","author":"Sa-nguanmoo","year":"2016","journal-title":"Metab. Brain Dis."},{"issue":"7","key":"10.1016\/j.neuropharm.2020.108335_bib33","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","article-title":"Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease","volume":"24","author":"Yun","year":"2018","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.neuropharm.2020.108335_bib34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/CS20150623","article-title":"Fenofibrate increases cardiac autophagy via FGF21\/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice","volume":"130","author":"Zhang","year":"2016","journal-title":"Clin. Sci. (Lond.)"},{"issue":"52","key":"10.1016\/j.neuropharm.2020.108335_bib35","doi-asserted-by":"crossref","first-page":"52ra73","DOI":"10.1126\/scitranslmed.3001059","article-title":"PGC-1\u03b1, a potential therapeutic target for early intervention in Parkinson's disease","volume":"2","author":"Zheng","year":"2010","journal-title":"Sci. Transl. Med."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820304032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820304032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:36:33Z","timestamp":1777426593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820304032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":35,"alternative-id":["S0028390820304032"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108335","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential therapeutic role of fibroblast growth factor 21 in neurodegeneration: Evidence for ameliorating parkinsonism via silent information regulator 2 homolog 1 and implication for gene therapy","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108335"}}